Brief: Clarity Pharmaceuticals Posts Loss For The Year A$24.6 Mln
24/08/2023 09:27
Aug 24 (Reuters) - Clarity Pharmaceuticals Ltd CU6.AX :
* LOSS FOR THE YEAR A$24.6 MILLION VERSUS LOSS A$23.8
MILLION
Source text for Eikon: ID:nASX2vd8b1
Further company coverage: CU6.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clarity Pharmaceuticals
See all newsBrief: Clarity Pharmaceuticals Signs Commercial Manufacturing Agreement
Brief: Clarity Signs A Large-Scale Manufacturing Supply Agreement For Copper-64 With Theragenics
Brief: Clarity Pharmaceuticals Signs A Large-Scale Manufacturing Supply Agreement
Australia's Clarity Pharmaceuticals rises on bagging cancer detection agent supply
Australia's Clarity Pharma surges as US FDA approves trial